Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11Benzinga • 02/23/21
SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus CapsidsBusiness Wire • 02/23/21
Sanofi: Information concerning the total number of voting rights and shares - January 2021GlobeNewsWire • 02/22/21
GlaxoSmithKline and Sanofi to push ahead with phase II trial of Covid-19 vaccineProactive Investors • 02/22/21
Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidateGlobeNewsWire • 02/22/21
Sanofi (SNY) CEO Paul Hudson on Q4 2020 Results & Capital Markets Day (Transcript)Seeking Alpha • 02/06/21
Sanofi Swings To Forth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By €500MBenzinga • 02/05/21
Capital Markets Day 2021: Sanofi progresses on its strategy to drive growth across its businesses and innovation with emerging leadership in immunologyGlobeNewsWire • 02/05/21